Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
International Journal of Clinical Oncology|October 21, 2023
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in JapanShuichi Morizane, Keita Nakane, Toshiaki Tanaka, et al.
Japanese Journal of Clinical Oncology|February 2, 2025
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUCYoichiro Tohi, Keita Kobayashi, Kei Daizumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 30, 2024
Japanese clinical practice guidelines for prostate cancer 2023Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, et al.
JCO Precision Oncology|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel TrialAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
The Lancet. Oncology|July 11, 2026
Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trialAkihiro Ito, Yoichi Arai, Yoshiyuki Kakehi, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
JNCI Cancer Spectrum|February 4, 2022
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate BiopsyShusuke Akamatsu, Naoki Terada, Ryo Takata, et al.
European Urology Oncology|July 18, 2024
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical RegistryChris Bangma, Paul Doan, Lin Zhu, et al.
NEJM Evidence|February 6, 2024
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate CancerNoel W Clarke, Andrew J Armstrong, Antoine Thiery-Vuillemin, et al.
Urologic Oncology|August 29, 2021
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinomaRikiya Taoka, Takashi Kobayashi, Yu Hidaka, et al.
Pageof 18